News
ProPhase Labs FY EPS $1.02 Misses $1.15 Estimate, Sales $122.65M Beat $121.33M Estimate
28 Mar 23
Earnings, News
Earnings Scheduled For March 28, 2023
28 Mar 23
Earnings
ProPhase Labs Earnings Preview
27 Mar 23
Earnings
HC Wainwright & Co. Reiterates Buy on ProPhase Labs, Maintains $15 Price Target
8 Mar 23
News, Price Target, Reiteration, Analyst Ratings
Prophase Labs Collaboration With mProbe And Dr. Christopher Hartley Of Mayo Clinic For The Continued Development Of Its BE-smart Esophageal Pre-cancer Diagnostic Screening Test
1 Mar 23
News, Health Care, Contracts, General
HC Wainwright & Co. Reiterates Buy on ProPhase Labs, Maintains $15 Price Target
23 Feb 23
News, Price Target, Reiteration, Analyst Ratings
ProPhase Labs Announces Plans To Initiate Clinical Trial Of Equivir, Goal To Launch Commercially In Q4 2023
22 Feb 23
Biotech, News, FDA, General
ProPhase Labs Esophageal Cancer Early Detection Test (BE-smart) Featured in Peer-Reviewed Article in the International Journal of Molecular Science
16 Feb 23
News, Health Care, General
HC Wainwright & Co. Reiterates Buy on ProPhase Labs, Maintains $15 Price Target
16 Feb 23
News, Price Target, Reiteration, Analyst Ratings
Prophase Labs' Prophase Labs Will Acquiring New Equipment Which Is Expected To Double Its Current Capacity For Pouch Packaging By Q2 Of 2023. Pharmaloz Is Also Planning For Expansion Of Its Lozenge Manufacturing Business
15 Feb 23
News, Health Care, General
HC Wainwright & Co. Reiterates Buy on ProPhase Labs, Maintains $15 Price Target
7 Feb 23
News, Price Target, Reiteration, Analyst Ratings
ProPhase Labs Expects To Initiate Preclinical Requirements For Investigational New Drug Application Submission For Linebacker-1 Cancer Co-Therapy Program In Q4 2023
6 Feb 23
News, FDA
A Look Into Healthcare Sector Value Stocks
23 Jan 23
News
12 Health Care Stocks Moving In Wednesday's After-Market Session
11 Jan 23
Movers
5 Value Stocks In The Healthcare Sector
9 Jan 23
News
Press releases
ProPhase Labs Announces Record Financial Results for the year ended December 31, 2022
28 Mar 23
Press Releases
Impact Biomedical Preparing A Potential Spinoff — What Does This Mean For Investors Of Holding Company DSS, Inc (NYSE American: DSS)?
27 Mar 23
ProPhase Labs to Host 2022 Year End Financial Results Conference Call on Tuesday, March 28, 2023 at 11:00 a.m. Eastern Time
21 Mar 23
Press Releases
ProPhase Labs' Nebula Genomics Subsidiary Introduces Lowest Ever NGS Pricing of $249 for its Whole Genome Sequencing DNA Test
7 Mar 23
Press Releases
DSS Announces Letter to Shareholders
2 Mar 23
Penny Stocks, Press Releases
ProPhase Labs Announces Collaboration with mProbe, Inc. and Mayo Clinic for the Continuing Development of BE-Smart Esophageal Pre-Cancer Diagnostic Screening Test
1 Mar 23
Press Releases
ProPhase Labs Announces Plans to Initiate Clinical Trial of Equivir (OTC)
22 Feb 23
Press Releases
ProPhase Labs Esophageal Cancer Early Detection Test (BE-smart) Featured in Peer-Reviewed Article in the International Journal of Molecular Science
16 Feb 23
Press Releases